2002December 20, 2002Codexis Announces Collaboration with Eli Lilly and Company for the Development Of Improved Fermentation Processes November 13, 2002Maxygen Increases Focus on Advancing Key Therapeutics and Reducing Costs October 29, 2002Maxygen Reports Third Quarter 2002 Financial Results October 28, 2002MaxyAg Announces Name Change to Verdia, Inc. October 7, 2002Intermune and Maxygen Announce Progress in Alliance to Develop Once-Weekly Actimmune October 4, 2002Codexis Announces Closing of $25 Million Private Financing October 1, 2002Maxygen Announces Webcast of Presentation at UBS Warburg Fourth Annual Global Life Sciences Conference September 24, 2002Codexis Announces Commercialization Royalties in DSM Collaboration September 19, 2002Maxygen Publishes Novel Approach to Regulation of the Human Immune Response September 17, 2002Codexis Announces Commercialization and Milestone Payments in Pfizer Collaboration August 21, 2002Maxygen Receives $2.4 Million Grant to Develop Cross Protective Vaccines July 30, 2002Maxygen Reports Second Quarter 2002 Financial Results July 24, 2002Maxygen Announces Appointment of Paul Spence, D.Phil.,to Senior Vice President of Research and Development, Human Therapeutics May 28, 2002Maxygen Announces Joint Venture with Delta and Pine Land Company to Develop Improved Cotton Seed Products May 13, 2002Maxygen Announces Major Advances in its MolecularBreeding™ Product Discovery Platform April 30, 2002Maxygen Reports First Quarter 2002 Financial Results April 17, 2002Codexis, Inc. and Cargill Dow Announce Collaboration to Improve Novel Process for Natureworks™ PLA April 9, 2002Maxygen Granted U.S. Patent Covering Synthetic Gene Assembly Technologies February 26, 2002Maxygen Announces Launch of Wholly-Owned Chemicals Subsidiary, Codexis, Inc. February 21, 2002Maxygen Announces Advancement of Improved Interferon Beta for Multiple Sclerosis February 12, 2002Maxygen Reports Fourth Quarter and Year End 2001 Financial Results February 7, 2002Maxygen’s Whole Genome Shuffling Technologies Open New Product Areas in Fermentation and Vaccines January 8, 2002Celltech and Maxygen Enter Into Antibody Collaboration
Return to News
|
